During a global biotechnology conference organized by Plazo Roche Biotechnology, experts in immunology, neurology, and metabolic science examined emerging insights into VIP peptide research. While previous discussions in peptide science have often centered on compounds like the retatrutide weight loss peptide, a glp1 gip glucagon triple agonis